B

Boditech Med Inc
KOSDAQ:206640

Watchlist Manager
Boditech Med Inc
KOSDAQ:206640
Watchlist
Price: 13 110 KRW 2.02%
Market Cap: ₩308B

Net Margin

17.9%
Current
Declining
by 1.4%
vs 3-y average of 19.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
17.9%
=
Net Income
₩27.2B
/
Revenue
₩151.8B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
17.9%
=
Net Income
₩27.2B
/
Revenue
₩151.8B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Boditech Med Inc
KOSDAQ:206640
281.1B KRW
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
187.1B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
184.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
139.3B USD
Loading...
US
Stryker Corp
NYSE:SYK
136.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.3B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.6B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.2B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
47.9B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.5B USD
Loading...

Market Distribution

Higher than 91% of companies in Korea
Percentile
91st
Based on 2 632 companies
91st percentile
17.9%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Boditech Med Inc
Glance View

Market Cap
308B KRW
Industry
Health Care

Boditech Med, Inc. engages in the provision of in-vitro diagnostics analyzers and reagents. The company is headquartered in Chuncheon, Gangwon-Do. The company went IPO on 2014-12-29. The firm is engaged in the manufacture and sale of antigen diagnostic kits and other products. In addition, the Company is engaged in the manufacture and sale of cancer diagnostic kit, drug concentration diagnostic kit and other products. The firm sells its products within domestic market and to overseas markets. The firm was established in 1998 and is located in Chuncheon-si, Gang-won-do, South Korea.

Intrinsic Value
20 187.44 KRW
Undervaluation 35%
Intrinsic Value
Price
B
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
17.9%
=
Net Income
₩27.2B
/
Revenue
₩151.8B
What is Boditech Med Inc's current Net Margin?

The current Net Margin for Boditech Med Inc is 17.9%, which is below its 3-year median of 19.4%.

How has Net Margin changed over time?

Over the last 3 years, Boditech Med Inc’s Net Margin has decreased from 19.9% to 17.9%. During this period, it reached a low of 17.1% on Jun 30, 2025 and a high of 21.9% on Jun 30, 2024.

Back to Top